New agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease

A newly developed agonistic antibody reduced the amyloid pathology in mice with Alzheimer's disease, signaling its promise as a potential treatment for the disease, according to a team of researchers at UTHealth Houston.

Related Keywords

Japan ,Osaka ,Texas ,United States ,Qingchun ,Anhui ,China ,Xiamen ,Fujian ,Peng Zhao ,Shanghai ,California ,Houston ,Chongqing ,Baylor College Of Medicine ,Zhiqiang ,Hainan ,Phyllis Gough Huffington ,Wei Cao ,Yingjun Zhao ,Emily Henderson ,Ningyan Zhang ,Yuanzhong Xu ,Lulin Jiang ,Hui Zheng ,Xin Li ,Leike Li ,Hisashi Arase ,Huaxi Xu ,Roberta Welch Distinguished University ,Welch Foundation ,Sanford Burnham Prebys Medical Discovery Institute ,Osaka University ,Mcgovern Medical School ,Chemistry At Mcgovern Medical School ,Texas Therapeutics Institute ,Research Institute Of Texas ,Xiamen University ,Distinguished University Chair ,Science Translational ,Brown Foundation Institute ,Molecular Medicine ,Human Diseases ,Mcgovern Medical ,Xuejun Fan ,Qingchun Tong ,Cullen Chair ,Phyllis Gough Huffington Distinguished Professor ,Houston Graduate School ,Baylor College ,Chongqing Medical University ,Cancer Prevention ,Research Institute ,Antibody ,Lzheimer 39s Disease ,Rain ,Dancer ,Medical School ,Medicine ,Icroglia ,Euron ,Pathology ,Eceptor ,Research ,Herapeutics ,